González-García, K.; Santos-Álvarez, J.C.; Velázquez-Enríquez, J.M.; Zertuche-Martínez, C.; Reyes-Jiménez, E.; Baltiérrez-Hoyos, R.; Vásquez-Garzón, V.R.
Evaluation of Antifibrotic Mechanisms of 3′5-Dimaleamylbenzoic Acid on Idiopathic Pulmonary Fibrosis: A Network Pharmacology and Molecular Docking Analysis. Drugs Drug Candidates 2024, 3, 860-878.
https://doi.org/10.3390/ddc3040048
AMA Style
González-García K, Santos-Álvarez JC, Velázquez-Enríquez JM, Zertuche-Martínez C, Reyes-Jiménez E, Baltiérrez-Hoyos R, Vásquez-Garzón VR.
Evaluation of Antifibrotic Mechanisms of 3′5-Dimaleamylbenzoic Acid on Idiopathic Pulmonary Fibrosis: A Network Pharmacology and Molecular Docking Analysis. Drugs and Drug Candidates. 2024; 3(4):860-878.
https://doi.org/10.3390/ddc3040048
Chicago/Turabian Style
González-García, Karina, Jovito Cesar Santos-Álvarez, Juan Manuel Velázquez-Enríquez, Cecilia Zertuche-Martínez, Edilburga Reyes-Jiménez, Rafael Baltiérrez-Hoyos, and Verónica Rocío Vásquez-Garzón.
2024. "Evaluation of Antifibrotic Mechanisms of 3′5-Dimaleamylbenzoic Acid on Idiopathic Pulmonary Fibrosis: A Network Pharmacology and Molecular Docking Analysis" Drugs and Drug Candidates 3, no. 4: 860-878.
https://doi.org/10.3390/ddc3040048
APA Style
González-García, K., Santos-Álvarez, J. C., Velázquez-Enríquez, J. M., Zertuche-Martínez, C., Reyes-Jiménez, E., Baltiérrez-Hoyos, R., & Vásquez-Garzón, V. R.
(2024). Evaluation of Antifibrotic Mechanisms of 3′5-Dimaleamylbenzoic Acid on Idiopathic Pulmonary Fibrosis: A Network Pharmacology and Molecular Docking Analysis. Drugs and Drug Candidates, 3(4), 860-878.
https://doi.org/10.3390/ddc3040048